T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures

Science Translational Medicine
Elizabeth TringhamTerrance P Snutch

Abstract

Absence seizures are a common seizure type in children with genetic generalized epilepsy and are characterized by a temporary loss of awareness, arrest of physical activity, and accompanying spike-and-wave discharges on an electroencephalogram. They arise from abnormal, hypersynchronous neuronal firing in brain thalamocortical circuits. Currently available therapeutic agents are only partially effective and act on multiple molecular targets, including γ-aminobutyric acid (GABA) transaminase, sodium channels, and calcium (Ca(2+)) channels. We sought to develop high-affinity T-type specific Ca(2+) channel antagonists and to assess their efficacy against absence seizures in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS) model. Using a rational drug design strategy that used knowledge from a previous N-type Ca(2+) channel pharmacophore and a high-throughput fluorometric Ca(2+) influx assay, we identified the T-type Ca(2+) channel blockers Z941 and Z944 as candidate agents and showed in thalamic slices that they attenuated burst firing of thalamic reticular nucleus neurons in GAERS. Upon administration to GAERS animals, Z941 and Z944 potently suppressed absence seizures by 85 to 90% via a mechanism distinct from the effec...Continue Reading

References

Apr 1, 1992·International Journal of Cardiology·J O Olubodun
Jun 3, 1982·Nature·R Llinás, H Jahnsen
Feb 1, 1995·Italian Journal of Neurological Sciences·C Marescaux, M Vergnes
Jan 1, 1996·Laryngo- rhino- otologie·P Dost
Jul 1, 1997·British Journal of Pharmacology·C C Kuo, L Lu
Feb 26, 1998·International Review of Neurobiology·I Mody
May 29, 1998·Progress in Neurobiology·L DanoberC Marescaux
Jan 29, 2000·Brain Research. Molecular Brain Research·E M TalleyD A Bayliss
Mar 11, 2003·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alain Destexhe, Terrence J Sejnowski
Jan 20, 2004·The Journal of Biological Chemistry·Houman KhosravaniGerald W Zamponi
Jun 4, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Inseon SongHee-Sup Shin
Aug 17, 2004·Epilepsy Currents·Vincenzo Crunelli, Nathalie Leresche
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jungryun LeeHee-Sup Shin
Jan 13, 2005·British Journal of Pharmacology·Pavle M JoksovicSlobodan M Todorovic
Jan 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Matthew P AndersonSusumu Tonegawa
Feb 8, 2005·Brain Research·Leanne M StroudMargaret J Morris
Apr 27, 2005·Annals of Neurology·Houman KhosravaniGerald W Zamponi
May 13, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iuliia VitkoEdward Perez-Reyes
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Terrance P Snutch
Mar 16, 2006·Journal of Pharmacological Sciences·Berna TerzioğluM Zafer Gören
Apr 22, 2006·The Journal of Physiology·Didier PinaultLászló Acsády
Apr 29, 2006·The Journal of Physiology·Pavle M JoksovicSlobodan M Todorovic
Aug 10, 2006·The Journal of Pharmacology and Experimental Therapeutics·Lige LiuTerence J O'Brien
Aug 15, 2006·Neuroscience Letters·Jianmin LiangXiru Wu
Dec 16, 2006·CNS & Neurological Disorders Drug Targets·Diego Contreras
Jan 12, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iuliia VitkoEdward Perez-Reyes
Mar 3, 2007·The European Journal of Neuroscience·Margaret J MorrisTerence J O'Brien
Jun 15, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pierre-Olivier PolackStéphane Charpier
Jul 14, 2007·CNS Drug Reviews·M Zafer Gören, Filiz Onat

❮ Previous
Next ❯

Citations

Feb 13, 2014·Pflügers Archiv : European journal of physiology·Eunji Cheong, Hee-Sup Shin
Jan 30, 2014·Nature Neuroscience·Stephen G Waxman, Gerald W Zamponi
Jul 24, 2014·Cellular and Molecular Life Sciences : CMLS·Shao-Nian YangPer-Olof Berggren
Jun 5, 2014·Expert Opinion on Investigational Drugs·Kinga SałatKatarzyna Kulig
Nov 7, 2015·Nature Reviews. Drug Discovery·Gerald W Zamponi
Dec 23, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Carla MarchettiBruno Burlando
Dec 19, 2012·Epilepsia·Nicholas P Poolos, Daniel Johnston
Jul 10, 2013·British Journal of Clinical Pharmacology·Kim L PowellTerence J O'Brien
Sep 1, 2015·Molecular and Cellular Neurosciences·Lina A MatschkeNiels Decher
Sep 20, 2015·Progress in Neurobiology·Samuel HeyesAnnette C Dolphin
Jul 25, 2015·Biochemical Pharmacology·Terrance P Snutch, Gerald W Zamponi
Aug 14, 2012·Biochimica Et Biophysica Acta·Stuart M Cain, Terrance P Snutch
Jun 24, 2014·Pflügers Archiv : European journal of physiology·Stuart M CainTerrance P Snutch
Feb 19, 2013·Biochimica Et Biophysica Acta·Eunji Cheong, Hee-Sup Shin
May 23, 2014·Frontiers in Neurology·Yucai ChenKeling Wang
May 29, 2016·Trends in Pharmacological Sciences·Gareth R TibbsPeter A Goldstein
Jun 14, 2017·British Journal of Pharmacology·Terrance P Snutch, Gerald W Zamponi
Jun 14, 2017·British Journal of Pharmacology·Jeffrey R McArthurDavid J Adams
Jul 26, 2017·Channels·Stuart M CainTerrance P Snutch
Sep 21, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Hak Kyun YangAe Nim Pae
Mar 17, 2012·Nature Reviews. Drug Discovery·Man Tsuey Tse
Aug 1, 2013·Physiological Reviews·Eunji Cheong, Hee-Sup Shin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.